Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study

NCT07698951 is registered in ClinicalTrials.gov with Recross Cardio, Inc. as lead sponsor.

NCT NCT07698951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study
Lead sponsor
Recross Cardio, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
June 17, 2026
Completion date
December 31, 2029
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryptogenic stroke, patent foramen ovale, pfo, pfo - patent foramen ovale, pfo-associated stroke